The role of combined adjuvant therapeutic drugs in modulating opioid dosage and pain status in cancer patients: a systematic review and meta-analysis
Abstract
BACKGROUND: The management of cancer-related pain primarily relies on opioid analgesics, yet their use is frequently complicated by adverse effects and inadequate pain relief at higher doses.
OBJECTIVES: To assess the effectiveness and safety of adjunctive medications in reducing opioid requirements and improving pain management in patients with cancer-related pain.
METHODS: A comprehensive literature search was performed in PubMed, Embase, and the Cochrane Library up to June 2024, encompassing all relevant records. Studies were included if they were randomized controlled trials (RCTs) or observational studies that compared the efficacy of combined adjuvant therapy with monotherapy using opioid analgesics for the management of cancer-related pain in adults and reported at least one pertinent outcome measure.
RESULTS: This analysis included 13 studies (10 RCTs, n = 711; 3 retrospective studies, n = 314) evaluating adjunctive therapies including NSAIDs, anticonvulsants, antidepressants, and corticosteroids. Combination therapy significantly reduced daily opioid consumption versus monotherapy ([MD] -18.84 mg; 95% CI -28.19 to -9.52; P < 0.0001), with significant reductions specifically for NSAIDs (MD -17.27; 95% CI -30.26 to -4.27; P = 0.009) and anticonvulsants (MD -28.02; 95% CI -47.42 to -8.62; P = 0.005). Adjunctive therapy also significantly improved pain scores with NSAIDs (MD -0.79; 95% CI -0.97 to -0.62; P < 0.00001), dexamethasone (MD -1.43; 95% CI -2.23 to -0.63; P =…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 711 participants or records.
Read the paper
Related studies
- Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2)
- In silico and in vitro studies: investigating the chemical composition, DFT, molecular docking, and dynamic simulation of Satureja candidissima (Munby) Briq essential oil as a potential antibacterial agent
- Quercetin combined with ciprofloxacin and gentamicin inhibits biofilm formation and virulence in Staphylococcus aureus
- In silico study of the mechanism of action, pharmacokinetic and toxicological properties of some N-methylanthranilates and their analogs
- Anticonvulsant Effects of Citronellal, Daidzin, and Phytol, Possibly Through GABAA Receptor and Voltage-Gated Sodium Channel Interaction Pathways: In Vivo and In Silico Studies
- 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as D3R-Selective Ligands for 3D-QSAR, Docking and Molecular Dynamics Simulation Studies
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.